| Title: |
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer |
| Authors: |
Nabhan, C; Villines, D; Valdez, T V; Tolzien, K; Lestingi, T M; Bitran, J D; Christner, S M; Egorin, M J; Beumer, J H |
| Source: |
British Journal of Cancer ; volume 107, issue 4, page 592-597 ; ISSN 0007-0920 1532-1827 |
| Publisher Information: |
Springer Science and Business Media LLC |
| Publication Year: |
2012 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1038/bjc.2012.312 |
| Availability: |
https://doi.org/10.1038/bjc.2012.312; http://www.nature.com/articles/bjc2012312.pdf; http://www.nature.com/articles/bjc2012312 |
| Rights: |
http://www.springer.com/tdm |
| Accession Number: |
edsbas.2ED28CE3 |
| Database: |
BASE |